Disease-free survival (DFS) in the lapatinib alone arm and expanded results of the phase III ALTTO trial (BIG 2-06; NCCTG (alliance) N063D) in the adjuvant treatment of HER2-positive early breast cancer (EBC) Meeting Abstract
| Authors: | Perez, E. A.; Holmes, E.; de Azambuja, E.; Dueck, A.; Baselga, J.; Viale, G.; Zujewski, J. A.; Goldhirsch, A.; Crescenzo, R.; Pritchard, K.; Wolff, A. C.; Jackisch, C.; Lang, I.; Untch, M.; Smith, I.; Boyle, F.; Xu, B.; Gomez, H. L.; Gelber, R. D.; Piccart, M. |
| Abstract Title: | Disease-free survival (DFS) in the lapatinib alone arm and expanded results of the phase III ALTTO trial (BIG 2-06; NCCTG (alliance) N063D) in the adjuvant treatment of HER2-positive early breast cancer (EBC) |
| Meeting Title: | 39th ESMO Congress (ESMO 2014) |
| Journal Title: | Annals of Oncology |
| Volume: | 25 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2014 Sep 26-30 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2014-09-01 |
| Language: | English |
| ACCESSION: | WOS:000346901000010 |
| DOI: | 10.1093/annonc/mdu438.2 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: LBA7 -- Source: Wos |
